Search

Oligometastatic Prostate Cancer: How Far Do We Go?
Management of Unfavorable Intermediate-Risk Prostate Cancer: Role of SBRT, Brachytherapy and Androgen Deprivation
Management of Small Cell Neuroendocrine Tumors of the Genitourinary Tract
Definitive and Salvage Radiation Therapy for Prostate Cancer
Implementation of a Prostate SBRT Program in the Community Setting
“Let’s Talk About It!” - Biology and Management of Sexual Toxicity Resulting from Prostate Cancer Radiotherapy
Sexuality After Cancer Therapy
Principles and Skills of Brachytherapy: Resident-Focused Essentials
Oligometastatic Prostate Cancer: A Multidisciplinary Approach to Patient Care
Revisiting Post-Prostatectomy Salvage Radiation in the Age of Precision Oncology
Androgen Deprivation Therapy and Dose Escalation for Prostate Cancer: Lessons from Randomized Trials and the MARCAP Consortium
Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making
Patient Reported Outcomes Following MR-guided Radiotherapy for Prostate Cancer: A Systematic Review and Meta-analysis
ROBIN Oligometastasis (OligoMET) Center: Using Biomarker Correlates from a Prostate Cancer Clinical Trial to Improve Future Outcomes
Renal SABR: Implementation of A New Standard of Care
Practical Radiation Oncology Program 2025
ASTRO/KCA Joint Activity: Stereotactic Radiotherapy and Renal Cell Cancer, Overcoming Radioresistance and the Resistance to Radiate
Contouring for Oligometastatic Prostate Cancer
Contemporary Multi-Disciplinary Management of Bladder Cancer
Empowering Prostate Cancer Patients: Combating Misinformation and Optimizing Lifestyle
Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline
Latest Developments in Management of High-Risk Prostate Cancer

You are here